In millions, except per share items | Dec-31-15 | Dec-31-14 | Dec-31-13 |
| 20-F | 20-F | 20-F |
Revenues: |
Netherlands | 10.6 | 2.1 | 8.4 |
Czech Republic and Slovakia | 0.0 | 0.6 | 1.8 |
Bulgaria | 0.2 | 0.1 | 1.9 |
Europe | 80.7 | 104.8 | 149.2 |
Other | 350.3 | 233.5 | 154.9 |
Total revenues | 441.8 | 341.1 | 316.2 |
Revenue growth [+] | 29.5% | 7.9% | |
Netherlands | 415.5% | -75.5% | |
Czech Republic and Slovakia | -98.8% | -64.2% | |
Bulgaria | 167.2% | -96.8% | |
Europe | -23.0% | -29.8% | |
India | 127.6% | -24.6% | |
Cost of goods sold | 418.3 | 330.5 | 301.0 |
Gross profit | 23.6 | 10.6 | 15.2 |
Gross margin | 5.3% | 3.1% | 4.8% |
Selling, general and administrative [+] | 61.0 | 38.4 | 46.4 |
Sales and marketing | 16.9 | 13.2 | 16.4 |
General and administrative | 44.1 | 25.2 | 30.0 |
Research and development | 3.1 | 3.2 | 6.0 |
Other operating expenses | 0.0 | 0.0 | -3.9 |
EBITDA [+] | -21.5 | -10.9 | -10.7 |
EBITDA growth | 97.6% | 1.9% | |
EBITDA margin | -4.9% | -3.2% | -3.4% |
Depreciation | 19.0 | 20.1 | 22.7 |
EBITA | -40.5 | -30.9 | -33.3 |
EBITA margin | -9.2% | -9.1% | -10.5% |
Amortization of intangibles | 0.0 | | |
EBIT [+] | -40.5 | -30.9 | -33.3 |
EBIT growth | 30.9% | -7.2% | |
EBIT margin | -9.2% | -9.1% | -10.5% |
Non-recurring items [+] | 0.0 | 0.0 | 3.9 |
Asset impairment | 0.0 | 0.0 | 2.1 |
Interest expense, net [+] | 22.3 | 22.3 | 22.2 |
Interest expense | 26.4 | 27.9 | 28.8 |
Interest income | 4.2 | 5.6 | 6.6 |
Other income (expense), net | -15.8 | -2.6 | 9.0 |
Pre-tax income | -78.6 | -55.9 | -50.5 |
Income taxes | 1.4 | 0.6 | 1.1 |
Minority interest | 0.5 | -0.4 | -1.0 |
Net income | -80.5 | -56.1 | -50.6 |
Net margin | -18.2% | -16.4% | -16.0% |
|
Basic EPS [+] | ($0.30) | ($0.21) | ($0.20) |
Growth | 43.5% | 5.8% | |
Diluted EPS [+] | ($0.30) | ($0.21) | ($0.20) |
Growth | 43.5% | 5.8% | |
|
Shares outstanding (basic) [+] | 267.3 | 267.3 | 255.1 |
Growth | 0.0% | 4.8% | |
Shares outstanding (diluted) [+] | 267.3 | 267.3 | 255.1 |
Growth | 0.0% | 4.8% | |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |